MDCX (Medicus Pharma) PB Ratio: 12.62 (As of Jul. 04, 2026)


MDCX Medicus Pharma Ltd MDCX
13 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is Medicus Pharma PB Ratio?

Medicus Pharma MDCX +4.07% 13 PB Ratio is 12.62 as of Jul. 04, 2026. GuruFocus rates MDCX with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 921 Drug Manufacturers companies, Medicus Pharma ranks worse than 94.79% on this metric.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-04), Medicus Pharma's share price is $0.4163. Medicus Pharma's Book Value per Share for the quarter that ended in Mar. 2026 was $0.03. Hence, Medicus Pharma's PB Ratio of today is 12.62.

The historical rank and industry rank for Medicus Pharma's PB Ratio or its related term are showing as below:

MDCX' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 12.62
Current: 12.62

During the past 5 years, Medicus Pharma's highest PB Ratio was 12.62. The lowest was 0.00. And the median was 0.00.

MDCX's PB Ratio is ranked worse than
94.79% of 921 companies
in the Drug Manufacturers industry
Industry Median: 1.91 vs MDCX: 12.62

During the past 12 months, Medicus Pharma's average Book Value Per Share Growth Rate was -101.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 87.40% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Medicus Pharma was 87.40% per year. The lowest was 87.40% per year. And the median was 87.40% per year.

Back to Basics: PB Ratio


Medicus Pharma  (NAS:MDCX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Medicus Pharma PB Ratio Related Terms


Medicus Pharma PB Ratio Historical Data

* Premium members only.

The historical data trend for Medicus Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicus Pharma PB Ratio Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
0.00 0.00 0.00 9.17 0.00

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.25 14.66 0.00 0.00 13.91

MDCX vs NSRX, MIRA, SCLX: PB Ratio Comparison

For the Drug Manufacturers - General subindustry, Medicus Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicus Pharma PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicus Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Medicus Pharma's PB Ratio falls into.


MDCX
13GF Score
Medicus Pharma Ltd MDCX
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicus Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Medicus Pharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2026)
=0.4163/0.033
=12.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →
What does a PB Ratio of 12.62 mean?
Medicus Pharma (MDCX) has a PB Ratio of 12.62 as of Jul. 04, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medicus Pharma and its competitors. According to the industry distribution chart, Medicus Pharma ranks #873 out of 921 companies in the Drug Manufacturers industry, placing it in the top 94.8%.
Is Medicus Pharma's PB Ratio too high?
Medicus Pharma's current PB Ratio is 12.62. The Drug Manufacturers industry median PB Ratio is 1.91. Medicus Pharma's value of 12.62 is 560.7% above this industry median. Based on the distribution chart, Medicus Pharma ranks #873 out of 921 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medicus Pharma has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Pharma's PB Ratio compare to NSRX and MIRA?
According to the Drug Manufacturers industry distribution chart, Medicus Pharma ranks #873 out of 921 companies for PB Ratio. This places Medicus Pharma in the lower half of its industry. The industry median PB Ratio is 1.91. Medicus Pharma's value of 12.62 is 560.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.91, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicus Pharma's current PB Ratio of 12.62 is 560.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medicus Pharma and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicus Pharma's current PB Ratio is 12.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Pharma stock overvalued right now?
Medicus Pharma (MDCX) has a current PB Ratio of 12.62. The current PB Ratio is 12.62 and 560.7% above the Drug Manufacturers industry median of 1.91. Medicus Pharma's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medicus Pharma (MDCX), the current PB Ratio is 12.62 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicus Pharma Business Description

Address 100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
13GF Score

Get the complete analysis for MDCX

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price